Bactericidal activity of metronidazole against Bacteroides fragilis
AUTOR(ES)
Whelan, J. P. F.
RESUMO
Metronidazole was found to be active against Bacteroides fragilis strains isolated from human lesions. The minimal inhibitory concentrations (MIC) were from 0·16 to 2·5 μg/ml and the minimal bactericidal concentrations (MBC) were from 0·16 to 2·5 μg/ml; usually the MIC and MBC figures were equivalent. These levels are easily attainable in the serum following normal therapeutic doses. The drug is not toxic and side effects are rare and it would therefore seem highly suitable for treating Bacteroides infections and also may be considered prophylactically in certain situations that are described.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=477766Documentos Relacionados
- Unique Bactericidal Action of Metronidazole Against Bacteroides fragilis and Clostridium perfringens
- Pharmacodynamics of Pulse Dosing versus Standard Dosing: In Vitro Metronidazole Activity against Bacteroides fragilis and Bacteroides thetaiotaomicron
- Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.
- Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis.
- In Vitro Activity of Josamycin and Rosamicin Against Bacteroides fragilis Compared with Clindamycin, Erythromycin, and Metronidazole